D042944Chemicals & DrugsD08.811.682.660.200220.999031Cholestenone 5 alpha-Reductaseprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson2156887Gormley GJ, Stoner E, Rittmaster RS, Gregg H, Thompson DL, Lasseter KC, Vlasses PH, Stein EAThe Journal of clinical endocrinology and metabolismEffects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteers. J Clin Endocrinol Metab. 1990 Apr; 70(4):1136-41.J Clin Endocrinol Metab1990-04-01T00:00:001990Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteers.20587837Chung DE, Kaplan SAArchivos espanoles de urologiaCurrent role for combination therapy in male LUTS. Arch Esp Urol. 2010 Jun; 63(5):323-32.Arch Esp Urol2010-06-01T00:00:002010Current role for combination therapy in male LUTS.3856037Brendler CB, Follansbee AL, Isaacs JTThe Journal of urologyDiscrimination between normal, hyperplastic and malignant human prostatic tissues by enzymatic profiles. J Urol. 1985 Mar; 133(3):495-501.J Urol1985-03-01T00:00:001985Discrimination between normal, hyperplastic and malignant human prostatic tissues by enzymatic profiles.0.09805010.09580612research area of0.3925810.01666014subject area forMedicineSurgeryUniversity of ChicagoDoreenChungDoreen Chung41.78927490000000-87.601250000000001295Chung, DoreenClinical AssociateDanielShevrinDaniel H. Shevrin41.78927490000000-87.60125000000000445Shevrin, DanielCLINICAL ASSOCIATE PROFESSORtrue1CLINICAL ASSOCIATE PROFESSORCLINICAL ASSOCIATE PROFESSORtrue1Clinical AssociateClinical Associate20564326Gupta S, Wang Y, Ramos-Garcia R, Shevrin D, Nelson JB, Wang ZThe ProstateInhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice. Prostate. 2010 Oct 01; 70(14):1575-85.Prostate2010-10-01T00:00:002010Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice.